Phase 1 Clinical Study of the Port Delivery System with ranibizumab for continuous treatment of neovascular age-related macular degeneration

Anat Loewenstein; Guna Laganovska; Neil M. Bressler; Juris Vanags; Yair Alster; Eugene De Juan; Jay M. Stewart; David Kardatzke; Genentech Inc California States; Genentech Inc California States

Phase 1 Clinical Study of the Port Delivery System with ranibizumab for continuous treatment of neovascular age-related macular degeneration

Anat Loewenstein, Guna Laganovska, Neil M. Bressler, Juris Vanags, Yair Alster, Eugene De Juan, Jay M. Stewart, David Kardatzke, Genentech Inc California States, Genentech Inc California States

Research output: Contribution to journal › Meeting Abstract › peer-review

Original language	English
Journal	Investigative Ophthalmology and Visual Science
Volume	61
Issue number	7
Publication status	Published - Jun 2020
Externally published	Yes
Event	Annual Meeting of the Association for Research in Vision and Ophthalmology - Baltimore, United States Duration: 3 May 2020 → 7 May 2020

Field of Science*

3.2 Clinical medicine

Publication Type*

3.3. Publications in conference proceedings indexed in Web of Science and/or Scopus database

Access to Document

https://iovs.arvojournals.org/article.aspx?articleid=2769145&resultClick=1Licence: CC BY-NC-ND

Cite this

Loewenstein, A., Laganovska, G., Bressler, N. M., Vanags, J., Alster, Y., De Juan, E., Stewart, J. M., Kardatzke, D., States, G. I. C., & States, G. I. C. (2020). Phase 1 Clinical Study of the Port Delivery System with ranibizumab for continuous treatment of neovascular age-related macular degeneration. Investigative Ophthalmology and Visual Science, 61(7). https://iovs.arvojournals.org/article.aspx?articleid=2769145&resultClick=1

@article{4b9b544fbd6348f8b6c28ab8d427059d,

title = "Phase 1 Clinical Study of the Port Delivery System with ranibizumab for continuous treatment of neovascular age-related macular degeneration",

author = "Anat Loewenstein and Guna Laganovska and Bressler, {Neil M.} and Juris Vanags and Yair Alster and {De Juan}, Eugene and Stewart, {Jay M.} and David Kardatzke and States, {Genentech Inc California} and States, {Genentech Inc California}",

year = "2020",

month = jun,

language = "English",

volume = "61",

journal = "Investigative Ophthalmology and Visual Science",

issn = "0146-0404",

publisher = "Association for Research in Vision and Ophthalmology Inc.",

number = "7",

note = "Annual Meeting of the Association for Research in Vision and Ophthalmology, ARVO ; Conference date: 03-05-2020 Through 07-05-2020",

}

Loewenstein, A, Laganovska, G, Bressler, NM, Vanags, J, Alster, Y, De Juan, E, Stewart, JM, Kardatzke, D, States, GIC & States, GIC 2020, 'Phase 1 Clinical Study of the Port Delivery System with ranibizumab for continuous treatment of neovascular age-related macular degeneration', Investigative Ophthalmology and Visual Science, vol. 61, no. 7. <https://iovs.arvojournals.org/article.aspx?articleid=2769145&resultClick=1>

TY - JOUR

T1 - Phase 1 Clinical Study of the Port Delivery System with ranibizumab for continuous treatment of neovascular age-related macular degeneration

AU - Loewenstein, Anat

AU - Laganovska, Guna

AU - Bressler, Neil M.

AU - Vanags, Juris

AU - Alster, Yair

AU - De Juan, Eugene

AU - Stewart, Jay M.

AU - Kardatzke, David

AU - States, Genentech Inc California

PY - 2020/6

Y1 - 2020/6

M3 - Meeting Abstract

SN - 0146-0404

VL - 61

JO - Investigative Ophthalmology and Visual Science

JF - Investigative Ophthalmology and Visual Science

IS - 7

T2 - Annual Meeting of the Association for Research in Vision and Ophthalmology

Y2 - 3 May 2020 through 7 May 2020

ER -